Cargando…
Neuropathology of drug addictions and substance misuse. Volume 3, General processes and mechanisms, prescription medications, caffeine and Areca, polydrug misuse, emerging addictions and non-drug addictions /
"Neuropathology of Drug Addictions and Substance Misuse, Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions "is the third of three volumes in this informative series and offers a comprehensi...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London ; San Diego, CA :
Academic Press,
[2016]
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover; Neuropathology of Drug Addictionsand Substance Misuse; Evolve Page ; Neuropathology of Drug Addictions and Substance Misuse: Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug Addictions; Copyright; Contents; List of Contributors; Preface; Acknowledgments; I
- Principles of Addictions, Overviews, Detailed Processes and Mechanisms; A
- General Aspects; 1
- Drugs and the Human Envirome; INTRODUCTION; THE HUMAN ENVIROME PROJECT; HISTORY AND BACKGROUND OF CURRENT POLITICAL ENVIRONMENTS.
- OTHER MACRO-LEVEL FACETS OF THE CURRENT INTERNATIONAL POLICY REGIMEDRUG POLICY EVALUATION, PIECE BY PIECE; CONCLUSIONS; SUMMARY POINTS; REFERENCES; 2
- Psychoactive Plants Used during Religious Rituals; INTRODUCTION; EVIDENCES AND FINDINGS; SUMMARY OF THE PSYCHOLOGICAL EFFECTS OF THE PSYCHOACTIVE PLANTS USED IN ANCIENT RELIGIOUS RITUALS; Lysergic Acid Diethylamide (LSD) and LSD-like Effects (in Mescaline, Psilocybin, DMT, Central Nervous System (CNS) Stimulants, i ... ; Opium (Narcotic Analgesics, Morphine); Cannabis sativa (THC); Ephedra (Ephedrine).
- Mandragora, Blue Water Lily (Atropine, Scopolamine), and Muscarine (Amanita Muscaria, Magic Mushrooms)Monoamine Oxidase Inhibitors (Peganum harmala; Harmine, Harmaline; Banisteriopsis caapi Vine); DMT (Ayahuasca Plants; Phalaris Species); 5-Hydroxy DMT (Bufotenin); Psilocybin (Magic Mushrooms); Ibogaine (Tabernanthe iboga); Salvia divinorum; Thujone (Wormwood; Artemisia absinthium); Mescaline (Peyote); DISCUSSION; Psychoactive Plants, H-ASCs, and Mystical Experience; What Can Be the Basis of Psychedelic Religious Experience?; APPLICATIONS TO OTHER ADDICTIONS AND SUBSTANCE MISUSE.
- DEFINITION OF TERMSKEY FACTS; SUMMARY POINTS; ACKNOWLEDGMENT; REFERENCES; 3
- Substance Use Disorders and Comorbid Mental Illness: A Focus on Epidemiological Data Regarding Mood and Anxiety Disorders; INTRODUCTION; MOOD AND ANXIETY DISORDERS AMONG INDIVIDUALS WITH SUDS; Mood and Anxiety Disorders among Individuals with AUD; Mood and Anxiety Disorders among Individuals with Cannabis Use Disorders; Mood and Anxiety Disorders among Individuals with Opioid Use Disorders; Mood and Anxiety Disorders among Individuals with Methamphetamine Use Disorders.
- Mood and Anxiety Disorders among Individuals with Cocaine Use DisordersPREVALENCE OF SUDS AMONG INDIVIDUALS WITH MOOD AND ANXIETY DISORDERS; SUDs among Individuals with MDD; SUDs among Individuals with BPD; SUDs among Individuals with SAD; SUDs among Individuals with GAD; SUDs among Individuals with Panic Disorder; LONGITUDINAL DATA-INCIDENCE OF SUDS AMONG INDIVIDUALS WITH MOOD AND ANXIETY DISORDERS; Unipolar Mood Disorders and the Future Development of SUDs; BPD and the Future Development of SUDs; SAD and the Future Development of SUDs; GAD, Panic Disorder, and the Future Development of SUDs.